ID Name Structure References (top 5) Molecular Target(s)
1ID:205
ALLANTOIN


NSC#:7606
Aldrich#:05670
Aldrich#:A28392
Aldrich#:A7878

Freqency:
in 5 ingredients:

  • 32
  • 122
  • 633
  • 730
  • 855
  • in 25 recipes:

  • 63
  • 97
  • 112
  • 119
  • 158
  • 162
  • 168
  • 225
  • 271
  • 301
  • 311
  • 312
  • 327
  • 329
  • 338
  • 351
  • 361
  • 362
  • 377
  • 389
  • 396
  • 452
  • 460
  • 490
  • 523

  • Properties
    C4H6N4O3    158.12





    1:  Desimone M, Catoni E, Ludewig U, Hilpert M, Schneider A, Kunze R, Tegeder M, Frommer WB, Schumacher K.
    A novel superfamily of transporters for allantoin and other oxo derivatives of nitrogen heterocyclic compounds in Arabidopsis.
    Plant Cell.    impact factor:   10.463
    2002;  14(4): 847-56

    2:  Doehner W, Schoene N, Rauchhaus M, Leyva-Leon F, Pavitt DV, Reaveley DA, Schuler G, Coats AJ, Anker SD, Hambrecht R.
    Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.
    Circulation.    impact factor:   9.903
    2002;  105(22): 2619-24

    3:  Kopprasch S, Pietzsch J, Kuhlisch E, Fuecker K, Temelkova-Kurktschiev T, Hanefeld M, Kuhne H, Julius U, Graessler J.
    In vivo evidence for increased oxidation of circulating LDL in impaired glucose tolerance.
    Diabetes.    impact factor:   9.019
    2002;  51(10): 3102-6

    4:  Goldman SC, Holcenberg JS, Finklestein JZ, Hutchinson R, Kreissman S, Johnson FL, Tou C, Harvey E, Morris E, Cairo MS.
    A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis.
    Blood.    impact factor:   8.782
    2001;  97(10): 2998-3003

    5:  Pui CH, Mahmoud HH, Wiley JM, Woods GM, Leverger G, Camitta B, Hastings C, Blaney SM, Relling MV, Reaman GH.
    Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma.
    J Clin Oncol.    impact factor:   7.963
    2001;  19(3): 697-704

    ARG
    BAD
    C-AMP
    FGF-2
    LC
    LRP
    MET
    MUSK
    P450
    ROS
    STEP
    TIE
     
    Time used: 234 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005